Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use
about
Influenza virosomes supplemented with GPI-0100 adjuvant: a potent vaccine formulation for antigen dose sparing.Role of CD8(+) T-cell immunity in influenza infection: potential use in future vaccine development.ISCOM-based vaccines: the second decade.Preparation and evaluation of an experimental iscom-based infectious bursal disease vaccineMice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response
P2860
Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use
description
article
@en
im Dezember 1998 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1998
@uk
name
Immunopotentiation of humoral ...... s with potential for human use
@en
Immunopotentiation of humoral ...... s with potential for human use
@nl
type
label
Immunopotentiation of humoral ...... s with potential for human use
@en
Immunopotentiation of humoral ...... s with potential for human use
@nl
prefLabel
Immunopotentiation of humoral ...... s with potential for human use
@en
Immunopotentiation of humoral ...... s with potential for human use
@nl
P2093
P1433
P1476
Immunopotentiation of humoral ...... s with potential for human use
@en
P2093
G Deliyannis
L Harling-McNabb
P304
P356
10.1016/S0264-410X(98)00080-2
P407
P577
1998-12-01T00:00:00Z